<DOC>
	<DOCNO>NCT00754910</DOCNO>
	<brief_summary>RATIONALE : Photodynamic therapy use drug becomes active expose certain kind light . When drug active , cancer cell kill . This may effective non-small cell lung cancer . PURPOSE : This clinical trial study well photodynamic therapy use porfimer sodium work treat patient non-small cell lung cancer bronchial disease .</brief_summary>
	<brief_title>Photodynamic Therapy Using Porfimer Sodium Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease</brief_title>
	<detailed_description>OBJECTIVES : Primary - To test hypothesis immune response non-small cell lung cancer patient treat photodynamic therapy ( PDT ) T cell mediate . Secondary - To test hypothesis PDT potentially affect survival rate patient . - To test hypothesis T lymphocytes mediate immune response affect survival PDT treat patient . OUTLINE : Patients deem suitable photodynamic therapy ( PDT ) offer PDT . Patients divide 2 group accord whether receive PDT . All patient refer radiation medical oncology standard care adjuvant therapy ( begin completion study ) . - Group 1 ( PDT ) : Patients receive porfimer sodium IV 3-5 minute undergo irradiation red light 48 hour later . Patients receive 2 treatment 2-day interval . - Group 2 ( non-PDT ) : Patients undergo baseline bronchoscopy repeat bronchoscopy 4 week . Blood sample , bronchoalveolar lavage fluid , tumor tissue collect treatment ( group 1 ) time bronchoscopy ( group 2 ) assay presence lymphocyte phenotype Th1 , Th2 , Treg , Th17 . After completion study therapy , patient follow 1 month PDT every 3 month 3 year . PROJECTED ACCRUAL : A total 236 patient ( 177 undergo photodynamic therapy [ PDT ] 59 undergoing PDT ) accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nonsmall cell lung cancer Any stage disease obstructive hemorrhagic endobronchial disease determine bronchoscopy No exist tracheoesophageal bronchoesophageal fistula No tumor erode major vessel PATIENT CHARACTERISTICS : No known porphyria allergy porphyrins PRIOR CONCURRENT THERAPY : See disease characteristic No prior photodynamic therapy , chemotherapy , radiotherapy No concurrent antioxidant therapy dietary supplement Not initiate chemotherapy radiotherapy study time ( 1 month post diagnostic bronchoscopy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
</DOC>